For quick production Corona vaccine: 375 million to Biontech

A. Martin UW Photography

Federal Research Minister Anja Karliczek (CDU) on Tuesday dampened hopes for a quick availability of a corona vaccine. For large parts of the population there will be a means only next year, she said on Tuesday. Safety is an absolute priority. A vaccine can only be used if the benefits are greater than the risks, Karliczek added. “We will not deviate from this line in Germany and Europe.” One still has to be prepared for the fact that there will not be a vaccine for large parts of the population until the middle of next year.

In addition to the Tübingen biotech company Curevac, the Mainz-based company Biontech is to receive 600 million euros in research funding for corona vaccine development, the research minister said. As had already reported exclusively at the beginning of September, 252 million euros of this will go to Curevac. In addition, Biontech is to receive 375 million.

For the accelerated research of corona vaccines, the Federal Ministry of Research started a special program with a funding pot of 750 million euros. According to Karliczek, the third company to be funded with this program is IDT Biologika from Dessau-Roßlau. The funding talks there are not yet fully completed.

According to the World Health Organization, around 170 projects around the world are looking for a vaccine. Test vaccinations are already running in 26 projects. In Russia, the first vaccine was approved for widespread use in the population before important tests were completed – something that was internationally criticized.

dpa / lp


Related Articles

Back to top button